Allurion Intends to Appeal NYSE Notice of Delisting, Execute Plan to Regain Compliance, and Expects to Continue Trading on NYSE

Generate Arrives on Nasdaq Ready To Finally Show the World AI-Powered Medicines

Pluri (NASDAQ: PLUR) regains key Nasdaq listing standard compliance

Wall Street futures fall on fears of protracted Middle East conflict

2 S&P 500 Stocks Turn $10,000 Into $36,541 In Two Months

S&P 500 See-Saws As Geopolitical Tensions Build